clinical trials
Tag details
Welcome to the 'clinical trials' tag page at Technorati. This page features content from the farthest reaches of the Blogosphere that authors have "tagged" with 'clinical trials'.
Latest blogosphere posts tagged “clinical trials”
-
ACT Seeks hESC Clinical Trial
California Stem Cell Report —
Authority: 135
Advanced Cell Technology has become the second U.S. company to seek permission to begin clinical trials for a therapy based on human embryonic stem cells.The Santa Monica, Ca., firm said yesterday that it has applied to the FDA to start trials aimed at reversing vision loss with retinal cells created from the stem ...1 day ago -
PI3K Pathway: A Potential Ovarian Cancer Therapeutic Target?
Libby's H*O*P*E* —
Authority: 113
…[T]here are several PI3K signaling pathway targeting drugs in clinical development for use against ovarian cancer and solid tumors, including GDC-0941, BEZ235, SF1126, XL-147, XL-765, BGT226, and PX-866. The results of two recent medical studies suggest that the use of PI3K-targeted therapies may offer an ...1 day ago -
Failed antidepressant is female viagra
Skin Care Blog —
Authority: 145
A ‘female Viagra’ that works on the pleasure centre of a woman’s brain to restore flagging libido could be on sale within two years. Women who take flibanserin once a day have sex more often and enjoy it more, large-scale trials have shown. The pill proved so popular that its German manufacturers are poised to ...2 days ago -
EKR Therapeutics Named Private Company of the Year By New Jersey Technology Council
Your Story —
Authority: 510
BEDMINSTER, N.J.--(BUSINESS WIRE)-- EKR Therapeutics, Inc., a specialty pharmaceutical company focused on commercializing acute-care hospital products, today announced that it has2 days ago -
Womens Viagra on its way?
Asylum.co.uk —
Authority: 581
Filed under: Sex , Women (Our happy hour fact to amaze your pub-going pals with.) A failed anti-depression drug may end the elusive search for the female version of Viagra. During its initial clinical testing, flibanserin didnt cheer women up; rather, many who took it ... Read more Permalink | ...2 days ago -
The New Face of Formatech.com
Your Story —
Authority: 510
ANDOVER, Mass.--(BUSINESS WIRE)-- Formatech, Inc is pleased to announce the launch of their new website. The redesigned site features detailed information about the variety of serv2 days ago -
The New Face of Formatech.com
Your Story —
Authority: 510
ANDOVER, Mass.--(BUSINESS WIRE)-- Formatech, Inc is pleased to announce the launch of their new website. The redesigned site features detailed information about the variety of serv2 days ago -
KineMed Receives an Investigator-Initiated Study Grant to Further Explore Mechanism(s) of Action Associated with Welchol® (colesevelam HCl) in Type 2 Diabetes Mellitus
Your Story —
Authority: 510
EMERYVILLE, Calif.--(BUSINESS WIRE)-- KineMed, Inc., a translational and personalized medicine development company, announced today that the company has received an investigator in3 days ago -
Company seeks FDA permission to conduct clinical trial using human embryonic stem cells
Booster Shots —
Authority: 692
Patients with a rare eye disease could be the first to be treated with human embryonic stem cells . Advanced Cell Technology Inc ., a Santa Monica-based biotech company with labs in Massachusetts, announced today that it has asked the U.S. Food and Drug Administration for approval to test retinal cells grown from ...3 days ago -
Clinical Trials Market in Russia
Press About —
Authority: 159
The Russian Clinical trials market has always enjoyed good returns since its inception, but its growth has been especially significant over the past few years, and is expected to post major growth in the future says our new report “Clinical Trials Market in Russia”. The number of Clinical trials conducted in ...3 days ago -
ImmuPharma PLC: Encouraging Final Phase IIb Results Seen with LUPUZOR™ in Systemic Lupus Erythematosus
Your Story —
Authority: 510
LONDON--(BUSINESS WIRE)-- ImmuPharma PLC (LSE:IMM) the specialist discovery and development pharmaceutical company is pleased to announce today the final results from a Phase IIb t3 days ago -
Womens Viagra May Be Coming
Asylum —
Authority: 736
Filed under: Sex , Dating/Love , Women , Happy Hour Hero Our happy hour fact to amaze your drinking buddies with. A failed anti-depression drug may end the elusive search for the female version of Viagra. During its initial clinical testing, flibanserin didnt cheer women up; rather, many who took it ... ...4 days ago -
Genzyme Halts Development of New Kidney Drug; A “Very Significant” Bust, Analyst Says
Xconomy —
Authority: 712
Biotech , Kidney Disease , Drugs Luke Timmerman wrote: Another day, another piece of bad news from Genzyme. The Cambridge, MA-based biotech giant (NASDAQ: GENZ ) said today it is scrapping development of a next-generation drug for kidney disease after it was unable to beat its existing treatment on ...4 days ago -
Anti-depressant could be the female answer to Viagra
Thaindian News —
Authority: 715
Sydney, November 18 (ANI): A drug that failed to pull women out of depression could work as their alternative to Viagra, experts believe.Lead North American investigator John Thorp, analysed tests of flibanserin, an active ingredient in Viagra along with sildenafil.The researcher found that though the drug fell short ...4 days ago -
Boehringer Ingelheim Announces Pivotal Phase III Data Of Flibanserin In Pre-Menopausal Women With Hypoactive Sexual Desire Disorder
Information on HPV —
Authority: 146
Data from pivotal Phase III clinical trials demonstrate that flibanserin 100mg increased the number of satisfying sexual events (SSE) and sexual desire (the co-primary endpoints) while decreasing the distress associated with Hypoactive Sexual Desire Disorder (HSDD). Flibanserin is an investigational compound being ...4 days ago -
Results From Phase 2b Study on Atrial Fibrillation Agent Reviewed at American Heart Association
Your Story —
Authority: 510
FREMONT, Calif.--(BUSINESS WIRE)-- ARYx Therapeutics, Inc. (NASDAQ:ARYX), a biopharmaceutical company, announced that a review of the results of the Phase 2b clinical trial, PASCAL4 days ago -
17 November, 2009 – This Week in Science Broadcast
This Week in Science - The Kickass Science Podcast —
Authority: 107
Making Memory Room, Oh Rats!, Hackers Hacking Pacemakers, New Breast Implants, A Tale of Two Drugs, iCough, Building Bigger Muscles, Push-Button Electric, Golden Ears, Right-Handed Chimps, Minion Mailbag, and More!!!4 days ago -
Researchers at Signature Genomics Diagnose Rare Syndrome in Children with Unexplained Mental Retardation and Birth Defects
Your Story —
Authority: 510
SPOKANE, Wash.--(BUSINESS WIRE)-- Researchers at Signature Genomic Laboratories, which performs diagnostic genetic testing of chromosome abnormalities in individuals with unexplain4 days ago -
Call for Bloggers: Attend Partnerships in Clinical Trials Asia Pacific on Us!
Partnerships in Clinical Trials —
Authority: 118
That’s right, we’re offering a few exclusive all-access complimentary passes to Partnerships in Clinical Trials Asia Pacific – December 1-3 in Singapore, and you could attend the conference – on us ($3,000+ value). We’re looking for experienced bloggers who are well-versed in clinical trials management to ...5 days ago -
Medtronic Launches the TSRH® 3Dx™ Spinal System
Your Story —
Authority: 510
MEMPHIS, Tenn.--(BUSINESS WIRE)-- Medtronic, Inc. (NYSE: MDT), today announced the launch of the TSRH® 3Dx™ Spinal System. Designed with procedural efficiency in mind, the TSRH 3Dx5 days ago

